164 related articles for article (PubMed ID: 38557089)
1. Does your unwell patient have haemophagocytic lymphohistiocytosis?
Holloway A; Ahmed S; Manson JJ
Br J Hosp Med (Lond); 2024 Mar; 85(3):1-12. PubMed ID: 38557089
[TBL] [Abstract][Full Text] [Related]
2. Intravenous anakinra for the treatment of haemophagocytic lymphohistiocytosis/macrophage activation syndrome: A systematic review.
Charlesworth JEG; Kavirayani A
Eur J Haematol; 2023 Sep; 111(3):458-476. PubMed ID: 37344166
[TBL] [Abstract][Full Text] [Related]
3. Diagnosing haemophagocytic syndrome.
Sen ES; Steward CG; Ramanan AV
Arch Dis Child; 2017 Mar; 102(3):279-284. PubMed ID: 27831908
[TBL] [Abstract][Full Text] [Related]
4. Continuous intravenous anakinra for treating severe secondary haemophagocytic lymphohistiocytosis/macrophage activation syndrome in critically ill children.
Charlesworth JEG; Wilson S; Qureshi A; Blanco E; Mitchell A; Segal S; Kelly D; Weitz J; O'Shea D; Bailey K; Kavirayani A
Pediatr Blood Cancer; 2021 Sep; 68(9):e29102. PubMed ID: 34114322
[TBL] [Abstract][Full Text] [Related]
5. Understanding the spectrum of haemophagocytic lymphohistiocytosis: update on diagnostic challenges and therapeutic options.
Brisse E; Matthys P; Wouters CH
Br J Haematol; 2016 Jul; 174(2):175-87. PubMed ID: 27292929
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-induced haemophagocytic syndrome.
Kumar N; Gadpayle AK; Singh R; Tonk RS; Dembla G
Natl Med J India; 2012; 25(5):271-3. PubMed ID: 23448626
[TBL] [Abstract][Full Text] [Related]
7. Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial.
Ahmed A; Merrill SA; Alsawah F; Bockenstedt P; Campagnaro E; Devata S; Gitlin SD; Kaminski M; Cusick A; Phillips T; Sood S; Talpaz M; Quiery A; Boonstra PS; Wilcox RA
Lancet Haematol; 2019 Dec; 6(12):e630-e637. PubMed ID: 31537486
[TBL] [Abstract][Full Text] [Related]
8. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
Soy M; Atagündüz P; Atagündüz I; Sucak GT
Rheumatol Int; 2021 Jan; 41(1):7-18. PubMed ID: 32588191
[TBL] [Abstract][Full Text] [Related]
9. Haemophagocytic syndrome and COVID-19.
Retamozo S; Brito-Zerón P; Sisó-Almirall A; Flores-Chávez A; Soto-Cárdenas MJ; Ramos-Casals M
Clin Rheumatol; 2021 Apr; 40(4):1233-1244. PubMed ID: 33389315
[TBL] [Abstract][Full Text] [Related]
10. Malignancy-associated haemophagocytic lymphohistiocytosis.
Setiadi A; Zoref-Lorenz A; Lee CY; Jordan MB; Chen LYC
Lancet Haematol; 2022 Mar; 9(3):e217-e227. PubMed ID: 35101205
[TBL] [Abstract][Full Text] [Related]
11. A rare case of secondary haemophagocytic lymphohistiocytosis in visceral leishmaniasis.
Singh H; Suri V; Gupta N
Trop Doct; 2022 Oct; 52(4):588-590. PubMed ID: 35880294
[TBL] [Abstract][Full Text] [Related]
12. Advances in the pathogenesis of primary and secondary haemophagocytic lymphohistiocytosis: differences and similarities.
Brisse E; Wouters CH; Matthys P
Br J Haematol; 2016 Jul; 174(2):203-17. PubMed ID: 27264204
[TBL] [Abstract][Full Text] [Related]
13. Haemophagocytic lymphohistiocytosis: an elusive syndrome.
Thomas W; Veer MV; Besser M
Clin Med (Lond); 2016 Oct; 16(5):432-436. PubMed ID: 27697804
[TBL] [Abstract][Full Text] [Related]
14. Hyperinflammatory syndrome resembling haemophagocytic lymphohistiocytosis following axicabtagene ciloleucel and brexucabtagene autoleucel.
Porter TJ; Lazarevic A; Ziggas JE; Fuchs E; Kim K; Byrnes H; Luznik L; Bolaños-Meade J; Ali SA; Shah NN; Wagner-Johnston N; Jain T
Br J Haematol; 2022 Dec; 199(5):720-727. PubMed ID: 36111395
[TBL] [Abstract][Full Text] [Related]
15. Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection.
Lorenz G; Schul L; Schraml F; Riedhammer KM; Einwächter H; Verbeek M; Slotta-Huspenina J; Schmaderer C; Küchle C; Heemann U; Moog P
Lupus; 2020 Mar; 29(3):324-333. PubMed ID: 32013725
[TBL] [Abstract][Full Text] [Related]
16. Cytokine Storms in the Course of COVID-19 and Haemophagocytic Lymphohistiocytosis in Pregnant and Postpartum Women.
Obuchowska A; Standyło A; Obuchowska K; Kimber-Trojnar Ż; Leszczyńska-Gorzelak B
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439868
[TBL] [Abstract][Full Text] [Related]
17. Haemophagocytic lymphohisticytosis-an underrecognized hyperinflammatory syndrome.
Hutchinson M; Tattersall RS; Manson JJ
Rheumatology (Oxford); 2019 Nov; 58(Suppl 6):vi23-vi30. PubMed ID: 31769857
[TBL] [Abstract][Full Text] [Related]
18. An incidental finding of severe hyperferritinaemia: a lesson to be learned.
Fretwell TB; Hanna M
J R Coll Physicians Edinb; 2018 Mar; 48(1):30-32. PubMed ID: 29741522
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced secondary haemophagocytic lymphohistiocytosis in hairy cell leukaemia.
Stark K; Rowe C; Mathur A; Matossian J; Lawrie A
J R Coll Physicians Edinb; 2024 Mar; 54(1):29-33. PubMed ID: 38160201
[TBL] [Abstract][Full Text] [Related]
20. Infections associated with haemophagocytic syndrome.
Rouphael NG; Talati NJ; Vaughan C; Cunningham K; Moreira R; Gould C
Lancet Infect Dis; 2007 Dec; 7(12):814-22. PubMed ID: 18045564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
